Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2023-02-15 Environmental & Social …
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
NXP002 Update
Environmental & Social Information Classification · 1% confidence The document is identified by the RNS Number (8876P) and the date (15 February 2023). The content is an update regarding the company's NXP002 programme, providing operational progress (acquiring tissue, commencing studies) and commentary from an executive. It is not a full financial report (like 10-K or IR), nor is it a formal proxy statement or dividend notice. Crucially, the footer explicitly states: "This information is provided by Reach, the non-regulatory press release distribution service of RNS... Reach announcements are identified with an orange label and the word “Reach"... Reach is a non-regulatory news service." This indicates it is a general corporate announcement distributed via the RNS system but classified as non-regulatory news. Since it is a general, non-specific corporate update that doesn't fit the other specific categories (like M&A, Capital Change, Management Change), the most appropriate fallback category is Regulatory Filings (RNS), which serves as the general announcement category for non-standard or non-mandated regulatory disclosures.
2023-02-15 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains an 'RNS Number'. It details changes in voting rights percentages (crossing thresholds from 10.76% to 8.94%) held by a shareholder ('Lanstead Capital Investors LP') in the issuer ('Nuformix plc'). This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-01-03 English
Nuformix hoping to 'initiate discussions with major pharma' in 2023
M&A Activity Classification · 1% confidence The document is very short (1457 characters) and appears to be a standard news release disseminated via the EQS News service. It contains a headline, date, company name (Nuformix PLC), and boilerplate text about the distribution service. It does not contain detailed financial statements (like 10-K or IR), specific voting results (DVA), or detailed management discussion (MDA). It is a general corporate announcement distributed through a regulatory/news wire service. Since it is a general announcement that doesn't fit the highly specific categories like ER, DIV, or MANG, the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings.
2022-12-20 English
NXP004 Update
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 2214K' and contains the footer information stating, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates a regulatory news service announcement. The content is an update on a specific drug program (NXP004) and announces positive results from dissolution studies, concluding with plans for pre-clinical models and discussions with commercialization partners. This is a general corporate update disseminated via the official regulatory news channel, which fits the definition of a Regulatory Filing (RNS) as a general announcement category, especially since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change (MANG/DIRS). The length (5942 chars) is substantial enough to be a substantive announcement, but the primary identifier is the RNS header/footer.
2022-12-20 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Half Year Report' for Nuformix plc, covering the six months ended 30 September 2022. It contains detailed operational highlights, financial highlights (loss before tax, loss per share, net assets), a Chairman's statement, and a 'Statement of Directors' Responsibilities' confirming the preparation of interim condensed financial statements in accordance with IAS 34. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2022
2022-12-13 English
Resignation of Auditor
Regulatory Filings Classification · 1% confidence The document is an official announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' and the footer information. The content announces the 'Resignation of Auditor' and cites specific sections of the Companies Act 2006. This type of corporate event announcement, which is not a standard financial report (like 10-K, IR, ER) or a specific insider transaction (DIRS), dividend (DIV), or management change (MANG), falls best under the general category for regulatory announcements that do not fit elsewhere. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short (3303 chars), but it is a primary announcement, not an announcement *of* another report, so RPA is less suitable than RNS for this specific regulatory event disclosure.
2022-12-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.